Company ProfilePremium

Banas Finance Limited

Company Profile Analysis

Ticker: 509053.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Banas Finance Limited - Company showcase

Year Founded & Workforce

1983

9 Employees

Banas Finance Limited logo

Banas Finance Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Banas Finance Limited Overview

Banas Finance Limited is a four-decade-old, Mumbai-based, non-deposit-taking NBFC that functions in practice as a proprietary investment and trading vehicle rather than a conventional lender. Its earnings are dominated by gains and losses on its equity investment portfolio and, since Q4 FY2024, by a commodity-trading book, with interest income from loans a small and only recently growing contributor. The company is controlled by the Agrawal family (promoter group 26.58%) and is the product of a 2020 three-way amalgamation that absorbed Proaim Enterprises, Axon Ventures and Rockon Enterprises. It raised ₹41.5 cr through a 2024 rights issue, carries virtually no debt, and trades at roughly 0.44x book value. Its defining characteristics are extreme earnings volatility (net results swinging from +₹69 cr to −₹54 cr in consecutive years), a nine-person organisation, thin disclosure, and a valuation that reflects heavy market scepticism about the quality and repeatability of earnings.


The company's own description

The company describes itself in exchange filings and on broker profiles (drawn from its annual report) as an RBI-registered non-deposit-taking NBFC engaged in "finance and share trading," and historically as being "engaged in finance, Share Trading, Investments, Consultancy and having interest in Realty business." Its memorandum objects are broad, covering purchase, leasing, factoring and hire-purchase financing of plant, machinery, vehicles, vessels, aircraft and other equipment, and acting as investors and dealers in shares, stocks and securities — explicitly excluding banking and insurance. Recent broker summaries of the annual report state the company operates a single primary segment of finance and share trading from which it derives its main revenue, and describe the company as consolidating its position after a 40-year journey (Groww summary of AR). From Q4 FY2024 onward, however, the company's own quarterly results disclose two reportable segments: (a) Finance Business Activities and (b) Commodity/Trading Business (Q1 FY2025 results filing, 10 Aug 2024).

Independent characterisation

Stripped of the broad memorandum language, Banas Finance's economic model has three components:

  1. Proprietary equity investment and trading. The bulk of the balance sheet is investments (₹91 cr of ₹138 cr total assets at 31 Mar 2026, consolidated). Income from this activity is recognised through the P&L as "net gain/loss on fair value changes" and through Other Comprehensive Income (OCI) for equity instruments designated at FVOCI. This is the dominant driver of reported results: Q3 FY2026's ₹40.5 cr standalone loss was primarily a ₹39.28 cr fair-value loss on investments. In FY2026, standalone PAT was ₹6.63 cr but total comprehensive income was a loss of ₹34.27 cr — i.e., the investment book lost substantially more than the P&L shows.

  2. Commodity trading. Introduced in Q4 FY2024, this is a buy-sell trading activity. It generates high gross revenue at thin or negative margins (Q3 FY2026: segment income ₹12.95 cr, segment loss ₹3.82 cr). The "cost of services provided" line rose from INR 87.1M (FY2022) to INR 424.0M (FY2026), consistent with traded-goods purchases being booked against trading revenue.

  3. Lending (inter-corporate deposits / loans). Interest and dividend income was only INR 3.69M in FY2024 and INR 5.77M in FY2025, before rising to INR 38.05M in FY2026 — the first year lending became a visible contributor. Provisions for loan losses have been significant relative to this income: INR 47.9M (FY2024), INR 201.4M (FY2025), INR 99.7M (FY2026).

Revenue model mix (analyst characterisation, FY2026): No product, subscription or licensing revenue. Revenue is entirely financial and trading: fair-value/realised investment gains, commodity sales, and interest income. The company does not disclose a formal revenue-by-type split in a retrievable form; based on StockAnalysis's line items for FY2026 (INR M): interest & dividend income 38.05; gain on sale of investments 18.27; "other revenue" (largely trading and fair-value income) 538.66.

Value-chain position: Capital provider and principal trader; it does not originate retail loans, has no branch network, no co-lending arrangements, and no disclosed fee businesses.

Customer types / end-markets: Not publicly disclosed in detail. Given the scale (nine employees, no branches), lending counterparties are likely a small number of corporate borrowers (inter-corporate deposits), and trading counterparties are commodity market participants. End-market is India only.

Strategy

Stated strategy. The company does not publish an investor presentation, does not hold investor days and has no earnings calls. Broker summaries of the annual report convey three themes: (1) the company's organisational changes aim to increase stakeholder value; (2) it seeks to expand its geographical reach; and (3) it aims to contribute positively to national economic growth, framed around an aspirational philosophy about embracing ambitions (Groww summary of AR). No quantified medium-term targets — loan book, ROE, AUM, cost ratios — are disclosed.

Initiatives in the last 24 months (Oct 2024 – Oct 2026):

ESG/sustainability commitments, cost programmes, guidance: None disclosed.

Products & Services

Banas Finance has no branded products, platforms or published price schedules. The complete catalogue of disclosed activities is:

No launch years, versions or flagship offerings exist in the conventional sense; "not publicly disclosed" applies to specifications, customer counts, ticket sizes and yields.

Product Portfolio

SegmentOfferingDescriptionTarget counterpartySincePricingSource

Finance

Corporate loans / inter-corporate deposits

Unsecured or secured lending to corporates; NBFC-ND licence permits lending from own funds

Corporate borrowers (identities not disclosed)

Pre-1999; scaled FY2026

Not disclosed; FY2026 interest & dividend income INR 38.05M

StockAnalysis

Finance

Proprietary equity investments

Holdings in listed and unlisted shares, recognised at fair value (FVTPL and FVOCI)

Own book

Long-standing

—

Q3 FY2026 results; FY2026 TCI

Finance

Share trading

Short-term buying and selling of securities

Own book

Long-standing

—

Company description

Finance

Associate investment

48.84% equity stake in Tilak Ventures Limited

———

ScanX

Commodity/Trading

Commodity trading

Buy-sell trading of commodities; type not disclosed

Market counterparties

Q4 FY2024

—

Q1 FY2025 filing

Other (historic)

Consultancy

Listed in company description; no revenue disclosed

—

Historic

—

Company CV

Other (historic)

Realty interest

————

Company CV; Screener

Memorandum objects (not evidenced as active)

Leasing, hire-purchase, factoring of plant, vehicles, vessels, aircraft, computers

Permitted under objects clause

—

1983 objects

—

Screener (AR-derived)

“—” = not publicly disclosed.

Financial Narrative

Income statement (consolidated unless stated; ₹ cr)

Gross profit: is not a meaningful metric for an NBFC and is not reported. EBITDA is approximated by operating profit before other income, interest and depreciation (depreciation is negligible; ₹0.0074 cr in FY2025). FY2026 PBT per the filing is ₹12.40 cr (₹1,239.85 lakh). EPS figures are as reported by Screener, which appears to adjust earlier years for the 2024 rights issue; unadjusted EPS on contemporaneous share counts would be materially higher for FY2022 — not separately verified.

Revenue build and cost lines

Zeros in FY2022–FY2023 interest income and FY2023/FY2025 investment-gain rows reflect the vendor showing no separate line ("–"), not necessarily nil activity.

Margins and growth (derived)

Revenue CAGR (derived): FY2022→FY2026 total income: (59.50/100.90)^(1/4) − 1 = −12.4% p.a. Screener reports a 5-year sales CAGR of 33% (FY2021 base of ~₹14 cr) and 3-year CAGR of 43% (FY2023 trough base). The choice of base year dominates the answer — itself a symptom of volatility.

Commentary. The five-year record shows no stable earnings base. FY2022's extraordinary ₹69 cr profit was almost entirely investment-driven (operating margin 93%) during the post-pandemic small-cap rally; FY2023's ₹54 cr loss reversed it as the same book was marked down (expenses of ₹120 cr against revenue of ₹20 cr, largely fair-value losses). FY2024 recovered to a modest ₹4.4 cr despite ₹34 cr PBT, owing to an unusual 93% effective tax rate (deferred tax movements of ₹30.75 cr appear in the FY2024 balance sheet per IIFL). FY2025 was a loss year with provisions for loan losses quadrupling to INR 201M — the clearest signal of credit stress in the lending book. FY2026 returned to profit at the P&L level (₹6.6–11.3 cr) with lending income becoming visible for the first time (INR 38M), but total comprehensive income was a ₹34.3 cr loss, meaning shareholders' equity shrank sharply. The inflection to watch is whether interest income can become a recurring base that dampens the fair-value swings.

Quarterly trajectory (consolidated, ₹ cr, Screener; Q3 FY2026 per filing)

Notes: Q3 FY2026 PBT and net profit are from the filing (Capital Market/Dion Global), replacing Screener's −1.22/−1.14. Q1 FY2027 net profit is the filing figure (₹286.72 lakh). Q2 FY2026 standalone net profit was reported as ₹9.33 cr (Dion Global). Q4 FY2026 net profit is reported as ₹6.81 cr by Screener/Capital Market but ₹4.46 cr by Kotak Neo — another vendor conflict. Q1 FY2026 net profit is shown as ₹10.63 cr by Screener but ₹0.69 cr by the company's Q1 FY2027 comparative (Investywise/Fyers); revenue for that quarter is ₹19.49 cr (Screener) vs ₹10.76 cr (Fyers). These differences likely reflect standalone vs consolidated and FVTPL vs FVOCI treatments and cannot be resolved without the primary filings.

Balance sheet (consolidated, ₹ cr, Screener)

Additional items: Short/long-term split of debt is not disclosed in retrievable form (borrowings are de minimis since FY2025). Cash & equivalents, goodwill and intangibles are not separately available; goodwill/intangibles are presumed nil (no acquisitions accounted under Ind AS 103 since the 2020 common-control merger). IIFL standalone data shows deferred tax liability of ₹30.75 cr (FY2024) and deferred tax asset of ₹25.30 cr (FY2023, FY2024). Net debt is not computable without cash; with ₹1 cr of borrowings it is approximately nil or negative. Working capital in the conventional sense is not meaningful for an NBFC; Screener reports working-capital days of 76 (FY2026) vs 205 (FY2025).

Commentary. The FY2025 increase in net worth to ₹182 cr was entirely the ₹41.5 cr rights issue; reserves actually fell by ₹16 cr. In FY2026 net worth fell by ₹44 cr to ₹138 cr — almost exactly the ₹34 cr comprehensive loss plus other adjustments — erasing the rights-issue capital in a single year. Book value per share fell from roughly ₹20.3 to ₹15.3. Investments fell from ₹128 cr to ₹91 cr, consistent with fair-value markdowns rather than disposals (cash from investing was a net outflow of ₹26 cr).

Cash flow (consolidated, ₹ cr, Screener)

FY2025 financing inflow of ₹36 cr reflects the rights issue (₹41.53 cr gross: 4,15,31,441 shares × ₹10) net of debt repayment (~₹5 cr). FY2026 operating cash flow of ₹24 cr is the strongest in the period (CFO/EBITDA 194% per Screener).

Ratios (derived unless stated)

Derivation notes: FY2021 net worth ₹92.42 cr and total assets ₹104 cr used as opening balances (IIFL/Screener). ROE FY2025 uses the −₹19.57 cr figure; on the ₹0.29 cr figure it would be 0.2%. ROE FY2026 on standalone PAT ₹6.63 cr would be 4.2%. Interest coverage is extreme in both directions because interest cost is tiny; it conveys little beyond "no leverage."

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipStakeNotesSource

Banas Finance Limited

Listed parent (NBFC)

—

All operations

BSE

Tilak Ventures Limited

Associate (equity-accounted)

48.84%

Contributes share of associate profit to consolidated results (₹8.47 lakh in Q3 FY2026)

ScanX Q3 FY2026

Subsidiaries

None disclosed

—

Consolidation arises from the associate

Q3 FY2026 results

Segment Overview

SegmentWhat it containsProducts/servicesStart

Finance Business Activities

Lending (loans/ICDs), investment in shares and securities, fair-value gains/losses, dividend and interest income

Corporate loans; proprietary equity portfolio

Since inception

Commodity/Trading Business

Purchase and sale of commodities

Commodity trading (specific commodities not disclosed)

Q4 FY2024

Revenue by Segment

Metric (INR Lakh)Q1FY2025Q3FY2026Q1FY2027

Commodity/Trading segment revenue

01,295.340

Finance segment revenue

0259.42299.14

Finance segment PBT

-730.420286.45

Commodity/Trading segment result

0-381.750

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Analysis

ItemSource ASource BSource CAssessment

FY2026 net profit

₹6.63 cr standalone PAT (Investywise, citing BSE; same figure shown for consolidated in the Q1 FY2027 filing summary)

₹11.33 cr consolidated (Capital Market via HDFC Sec; StockAnalysis INR 113.25M; Screener ₹11 cr)

—

Standalone PAT ₹6.63 cr is from the filing summary. The ₹11.33 cr consolidated figure is used by three data vendors. Unresolved; both shown.

FY2025 net profit

₹0.29 cr consolidated (Capital Market; Screener EPS ₹0.03)

−₹19.57 cr (StockAnalysis INR −195.7M; an earlier Screener snapshot showed ROE −11.6%)

−₹5.98 cr standalone (Investywise, as prior-year comparative)

Material conflict. Screener's own FY2025 quarterly figures sum to −₹6.92 cr, closest to the standalone −₹5.98 cr.

FY2025 operating profit

−₹18 cr (current Screener)

−₹38 cr (earlier Screener snapshot)

—

Restated by vendor; current figure shown.

Q3 FY2026 net result

−₹40.42 cr consolidated / −₹40.50 cr standalone (Capital Market; Dion Global; ScanX)

−₹1.14 cr (Screener quarterly table)

—

The filing-based −₹40.5 cr is preferred; Screener's quarter appears to exclude fair-value losses (possibly reclassified to OCI at year end).

Q1 FY2027 net profit

₹2.87 cr (standalone and consolidated per filing summary)

₹4.97 cr (Screener consolidated)

—

Filing summary preferred.

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr, IIFL)

97.8020.4466.6443.2357.23

Other income (INR Cr, IIFL)

3.020.447.000.262.27

Total income as reported (INR Cr, StockAnalysis)

100.9020.8873.6443.4859.50

Operating profit / EBITDA proxy (INR Cr, Screener)

91-10033-1813

Profit before tax (INR Cr, Screener)

92-10034-1812

Net profit – vendor consolidated (INR Cr, StockAnalysis)

69.18-53.584.40-19.5711.33

Basic EPS (₹, Screener, share-count adjusted)

6.88-5.580.460.031.26

Dividend per share (INR)

00000

Dividends & Capital Returns

MetricFY2022FY2023FY2024FY2025FY2026

Interest and dividend income (INR Mn)

003.695.7738.05

Gain on sale of investments (INR Mn)

30.22063.07018.27

Other revenue incl. trading and fair value (INR Mn)

975.71202.41669.33429.05538.66

Interest expense (INR Mn)

1.090.940.870.391.98

Provision for loan losses (INR Mn)

-2.4119.9047.94201.4499.68

Employee benefits (INR Mn)

3.4712.4710.9322.5328.71

Cost of services provided (INR Mn)

87.10187.97330.01377.13424.03

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating (EBITDA proxy) margin % on revenue from ops

93.0-489.249.5-41.622.7

Net margin % on total income (vendor NP)

68.6-256.66.0-45.019.0

Total income growth % YoY

805.5-79.3252.7-41.036.8

Income Statement

MetricQ1FY2025Q2FY2025Q3FY2025Q4FY2025Q1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027

Revenue from operations (INR Cr)

6.088.2030.574.1019.4918.9912.9520.812.99

Profit before tax (INR Cr)

-7.25-10.15-0.45-4.629.569.44-40.5010.612.87

Net profit (INR Cr)

-6.57-9.530.678.5110.6310.99-40.426.812.87

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

189159167183138

Equity share capital (INR Cr)

2648489090

Reserves (INR Cr)

1361041089248

Net worth (INR Cr)

162152156182138

Borrowings (INR Cr)

77611

Investments (INR Cr)

1398911212891

Fixed assets (INR Cr)

00099

Other assets incl. loans and cash (INR Cr)

5070564638

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

20-1-6024

Cash from investing activities (INR Cr)

-6-498-39-26

Cash from financing activities (INR Cr)

-444-1360

Net cash flow (INR Cr)

10-62-2-2

Capex (INR Cr)

00000

Free cash flow (INR Cr)

20-1-6024

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE % (vendor NP / average net worth)

54.3-34.22.9-11.67.1

ROA % (vendor NP / average total assets)

47.2-30.82.7-11.27.1

ROCE % (Screener)

67-6121-108

Debt to equity (x)

0.040.050.040.010.01

Interest coverage (x, PBT plus interest over interest)

845-1,063392-46064

Asset turnover (x, total income / average assets)

0.690.120.450.250.37

Revenue by Region (%) and Results by Region

RegionFY2024FY2025FY2026

India share of total income (%)

100100100

India total income (INR Cr)

73.6443.4859.50

India growth YoY (%)

252.7-41.036.8

Valuation Snapshot

MetricValueSource

Last close

₹6.70 (19 Oct 2026)

Screener

52-week high / low

₹9.89 / ₹5.01

Screener

1-year return

−16%

Screener price CAGR

3-year return (CAGR)

−28% p.a. (cumulative ≈ −40%; Anand Rathi cites −39.66%)

Screener; Anand Rathi

5-year return (CAGR)

−8% p.a.

Screener

10-year return (CAGR)

+6% p.a.

Screener

Metric

FY2022

FY2023

Net worth per share (₹, derived on 89.58M shares)

18.117.0

Valuation Multiples

MultipleBanas FinancePeer referenceNote

P/E (TTM)

2.8x

Industry P/E ~21x (Groww); micro-cap peer median ~21x (Value Research)

TTM profit per Screener ₹21.6 cr; on filing-based quarters TTM would be lower (and negative including Q3 FY2026's ₹40.5 cr loss — Anand Rathi shows P/E −2.13)

P/B

0.44x

Peer median ~0.82x (Value Research, Jun 2026)

Book value ₹15.3

EV/Sales (TTM)

~1.1x (derived)

—

EV ≈ ₹61 cr (mcap ₹60 cr + ~₹1 cr debt; cash not deducted) / TTM revenue ₹56.4 cr

EV/EBITDA (TTM)

~3.2x (derived)

—

TTM operating profit ₹19 cr (Screener)

Action by Date

DateAction

29 Aug 2017

10:1 stock split (ex-date)

Aug–Sep 2020

Shares issued to transferor-company holders under amalgamation

26 Apr 2024

Rights issue record date (1:1 at ₹10)

5 Jun 2024

Rights allotment of 4,15,31,441 shares

Analyst Conclusions

Management guidance and consensus

No guidance is issued and no consensus exists. The next scheduled datapoint is Q2 FY2027 (quarter ended 30 Sep 2026) results; the trading window closed on 1 Oct 2026, and on the company's historical cadence the board meeting is likely in mid-November 2026 (FY2026 Q2 results were approved on 14 Nov 2025).

Bull case

  1. Deep asset discount with a recovering book. At 0.44x book and with Q1 FY2027 comprehensive income of +₹29.3 cr already recouping most of FY2026's ₹34.3 cr OCI loss, book value could rebuild toward ₹18–19 per share if markets hold — making the discount even wider.

  2. Emergent lending earnings. Interest income rose roughly 6.6x in FY2026 to INR 38M, and FY2026 operating cash flow of ₹24 cr was the strongest in five years; a steadier lending base could reduce dependence on marks.

  3. Clean balance sheet and capital optionality. With ~₹1 cr of debt, the company can lend, buy back shares or distribute without balance-sheet stress.

Bear case

  1. Earnings are not "earnings." Reported profits are dominated by mark-to-market swings; FY2026's positive PAT coexisted with a ₹34 cr comprehensive loss, and the rights-issue capital raised in 2024 was effectively consumed within two years.

  2. Credit quality. Provisions of INR 201M in FY2025 and INR 100M in FY2026 against much smaller interest income imply the lending book has been loss-making on a risk-adjusted basis.

  3. Governance and disclosure discount is justified. Filing corrections, auditor-report revision, CFO and secretarial-auditor turnover, related-party approvals, a large public-category block holder, data conflicts across every major vendor, and no dividends despite profitable years all argue the P/B discount is structural rather than an anomaly.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
Q2 FY2027 results~Nov 2026Whether OCI gains persist; interest income run-rate; any commodity-segment revival
Q3 FY2027 results~Feb 2027Year-on-year comparison against Q3 FY2026's ₹40.5 cr loss
FY2027 audited results~May 2027Full-year TCI vs PAT; provisions; net worth per share
Shareholding patternsQuarterlyAny change in Prismx Global Ventures' 23.12% or promoter 26.58%
Related-party transactionsAR FY2027Nature and size of transactions approved at 2026 AGM
RegulatoryOngoingRBI scale-based regulation compliance; any BSE/SEBI queries
Capital allocationAny timeDividend initiation or buyback (would signal governance improvement)
Management stabilityOngoingTenure of new CFO; company-secretary disclosure

Analyst verdict

Banas Finance Limited is best understood not as a lender but as a small, family-controlled, listed investment vehicle wearing an NBFC licence. Its five-year record — a ₹69 cr profit, a ₹54 cr loss, a marginal year, a disputed loss year and a modest profit accompanied by a ₹34 cr comprehensive loss — demonstrates that the business has no stable earnings engine. The commodity-trading diversification launched in early 2024 has added revenue without adding profit, and the small lending book has, on the available numbers, generated more provisions than interest over FY2025–FY2026.

The valuation already reflects much of this. At roughly ₹60 cr of market value against ₹138 cr of book equity, investors are paying about 44 paise per rupee of stated net assets, and the near-absence of debt means there is little balance-sheet risk of permanent capital impairment from leverage. The early-FY2027 recovery in investment marks and the step-up in interest income are genuine, if early, positives, and a new CFO with consolidation and compliance experience could improve financial reporting.

Yet the discount is unlikely to close on fundamentals alone. Value realisation at a sub-book holding company typically requires a catalyst — dividends, buybacks, asset sales or a credible, scaled lending strategy — and none has been announced. Meanwhile the governance signals (filing corrections, auditor-report revision, management turnover, related-party approvals, a large public-category block holder) and the striking inconsistency of the company's financials across every data provider argue for caution about whether book value itself is reliable.

Verdict: a speculative, event-dependent deep-value situation with low information quality. Absent a capital-return or strategic catalyst, the base case is that the stock continues to trade at a wide discount to book, with quarterly results driven by small-cap equity market direction rather than by the company's own operating performance.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameDesignationSinceBackgroundAgeSource

Mrs. Tanu Girraj Agrawal (DIN 00290966)

Executive Director & CEO; promoter

Director long-standing; CEO from Jan 2024

B.Sc.; previously MD (from 1 Aug 2018) and Chairman/CEO of Rockon Enterprises Ltd (merged into Banas 2020)

~56 (aggregator)

BSE 30 Jan 2024; Simply Wall St

Mr. Girraj Kishor (G K) Agrawal

Executive Director; promoter

Long-standing

Chartered Accountant; experience in taxation, corporate law, ICDs, bill discounting, project and hire-purchase finance; spouse of Tanu Agrawal; described as heading the board and overseeing finance and administration

—

BSE 16 Jan 2024; InvestYadnya

Mr. Vikash (Vikas) Kulhriya

Independent Non-Executive Director

31 Dec 2020; reappointed for second term at AGM 24 Sep 2026

——

TheCompanyCheck; BSE 24 Sep 2026

Mr. Ashish Kachhara

Independent Non-Executive Director

Not disclosed (aggregator tenure ~2.8 years as of 2025)

——

Blinkx; Simply Wall St

Mr. Anant Chourasia (DIN 09305661)

Non-Executive Director (appointed Jan 2024 as Non-Independent; later aggregators list him as Independent — designation conflict)

16 Jan 2024 (additional); 30 May 2024 (regularised)

B.Com, MBA (Marketing & Finance); MD of Indian Infotech & Software Ltd (from Aug 2024); director at Surya Industrial Corp and Equilateral Enterprises

—

BSE 16 Jan 2024; MarketScreener; Directors' Report FY2025

“—” = not publicly disclosed.

Executive Leadership Team

NameRoleTenureNoteSource

Tanu Agrawal

CEO

Jan 2024 – present

Also Executive Director

BSE

Praveen Jangid

Chief Financial Officer

29 Jun 2026 – present

~10 years' experience in accounting operations, statutory compliance, consolidation, cash-flow management

ScanX; Groww

Amit Mehta

Former CFO

to 31 Mar 2026

Resigned (letter 16 Mar 2026), personal reasons

Screener; ScanX

Company Secretary & Compliance Officer

—

~6 years per aggregator

—

MarketsMojo; Simply Wall St

Board of Directors by Person

PersonRoleSalary (INR Mn)Bonus (INR Mn)Stock (INR Mn)Total (INR Mn)Source

Tanu Agrawal

CEO & ED

8.40008.40

Simply Wall St (S&P data, FY2024/25)

Company Secretary

CS & Compliance Officer

0.675000.675

Simply Wall St

Vikash Kulhriya

Independent Director

0.096 (fees)

000.096

Simply Wall St

Other Independent Director

Independent Director

0.096 (fees)

000.096

Simply Wall St

Governance Detail

CategorySep2023Mar2024Jun2024Mar2025Mar2026Jun2026

Promoter and promoter group %

17.5917.5926.5826.5826.5826.58

DIIs %

0.050.050.030.030.030.03

FIIs %

000000

Public %

82.3782.3673.3973.3973.3873.39

Number of shareholders

43,14038,80140,84439,35636,69236,206

Major Shareholders

HolderCategorySharesStake %As ofSource

Prismx Global Ventures Limited

Public (non-promoter body corporate)

~20.7 M (derived)

23.12

Mar 2026

MarketsMojo

Handful Investrade Pvt Ltd

Promoter group

9.563 M

10.68

Sep 2025

Emkay/Dion Global

Hunnar Jewels

Promoter group

9.383 M

10.48

Sep 2025

Emkay/Dion Global

Girraj Kishor Agrawal

Promoter (individual)

2,690,9663.00

Dec 2025

Emkay/BSE SHP

Tanu Agrawal

Promoter (individual)

2,173,2702.43

Dec 2025

Emkay/BSE SHP

Domestic institutions (aggregate)

DII

—0.03

Jun 2026

Upstox

Mutual funds / FIIs

—00

Jun 2026

Upstox

Competitive Landscape

Key Competitors

PeerSegment overlapScale indicatorRelative positioningSource

Bajaj Finance

Lending (retail/SME)

Market cap ~₹6.5 lakh cr; annual PAT ~₹19,017 cr

Category leader; no practical overlap

Fyers peer table

Shriram Finance

Vehicle/MSME lending

Market cap ~₹2.47 lakh cr; PAT ~₹10,024 cr

No practical overlap

Fyers

Cholamandalam Investment & Finance

Vehicle/home/SME lending

Market cap ~₹1.59 lakh cr; PAT ~₹5,233 cr

No practical overlap

Fyers

Tata Capital

Diversified lending

Market cap ~₹1.58 lakh cr; PAT ~₹4,846 cr

No practical overlap

Fyers

Jio Financial Services

Diversified financial services / investments

Market cap ~₹1.57 lakh cr; PAT ~₹1,561 cr

Investment-holding model is conceptually closest of the large peers

Fyers

Muthoot Finance

Gold loans

Market cap ~₹1.18 lakh cr; PAT ~₹10,590 cr

No practical overlap

Fyers

Charter Capital

Micro-cap NBFC/investment

—

Direct micro-cap peer

MarketsMojo peer list

Kapil Raj Finance

Micro-cap NBFC

—

Direct micro-cap peer

MarketsMojo

Real Touch Finance

Micro-cap NBFC

—

Direct micro-cap peer

MarketsMojo

Ceejay Finance

Small vehicle-finance NBFC

—

Small-lender peer

MarketsMojo

Tilak Ventures

Associate; micro-cap NBFC

—

Related party, not competitor

ScanX

Peer Comparison FY2026

MetricBanas FinanceBajaj FinanceShriram FinanceCholamandalam

Market cap (INR Cr)

60650,674246,828158,685

Annual PAT (INR Cr)

1119,01710,0245,233

P/E (x)

2.832.121.827.6

R&D intensity (%)

0000

Company Snapshot

$6.6M

Revenue

9

Employees

1983

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Near-zero leverage: borrowings of ~₹1 cr against net worth of ₹138 cr at 31 Mar 2026 (Screener); debt/equity 0.01x.
  • Deep discount to book: P/B ~0.44x at ₹6.70 vs book value ₹15.3 (Screener, Oct 2026).
  • Positive FY2026 operating cash flow: ₹24 cr, the best in five years (Screener).
  • Proven equity-raising access: ₹41.5 cr raised via rights issue in June 2024 at ₹10/share (BSE filing 5 Jun 2024).
  • RBI NBFC licence: registered non-deposit-taking NBFC since conversion application in 1999 (Screener/AR).
  • Lean cost base: nine employees; employee cost INR 28.7M in FY2026 (Simply Wall St; StockAnalysis).
  • Clean audit opinions: unmodified opinions on FY2023 and FY2026 results (BSE May 2023; ScanX Jul 2026).

Weaknesses

  • Extreme earnings volatility: consolidated net profit +₹69.2 cr (FY2022), −₹53.6 cr (FY2023), +₹4.4 cr (FY2024) (StockAnalysis).
  • Equity erosion in FY2026: total comprehensive loss of ₹34.27 cr (standalone) despite positive PAT; net worth fell ₹44 cr (Investywise; Screener).
  • Loss-making commodity segment: Q3 FY2026 segment loss ₹3.82 cr on ₹12.95 cr income (ScanX).
  • High credit costs: provisions for loan losses INR 201.4M in FY2025 and INR 99.7M in FY2026, vs interest income of INR 5.8M and INR 38.1M respectively (StockAnalysis).
  • Poor disclosure quality: WordPress website; erroneous filing corrected Jan 2024; revised auditor's report Jul 2026 (BSE; ScanX).
  • Low promoter stake: 26.58%, with a public-category holder (Prismx, 23.12%) of nearly equal size (Screener; MarketsMojo).
  • No dividend ever paid in the five-year window despite profitable years (Screener: dividend payout 0%).

Opportunities

  • Lending pivot: interest & dividend income grew from INR 5.8M (FY2025) to INR 38.1M (FY2026); scaling this could stabilise earnings.
  • Fair-value recovery: Q1 FY2027 TCI of +₹29.3 cr (standalone) recouped most of FY2026's ₹34.3 cr OCI loss (Investywise).
  • Value unlock at sub-book valuation: at 0.44x P/B, a buyback, dividend or asset monetisation would be accretive (Screener).
  • Associate value: 48.84% stake in Tilak Ventures could be monetised or consolidated (ScanX).
  • Strengthened finance function: new CFO from 29 Jun 2026 with consolidation and compliance background (ScanX).
  • Low cost of funds headroom: with ~₹1 cr debt, modest leverage could increase lending capacity if credit quality permits (Screener).

Threats

  • Equity market drawdown: Q3 FY2026 demonstrated a single quarter's fair-value loss (₹39.3 cr) can exceed an entire year's P&L (ScanX).
  • RBI regulatory tightening for small NBFCs on governance and investment concentration (analyst assessment; no specific action against Banas identified).
  • Credit losses on concentrated loans: FY2025 provisions of INR 201M equalled ~11% of FY2025 opening net worth (derived).
  • Liquidity/exit risk: ~₹64 cr market cap and ~12k shares daily volume (MarketsMojo) limit investor exits and capital-raising.
  • Key-person risk: 2023 death of MD Amit Gulecha and 2026 CFO turnover show thin management bench (IIFL; Screener).
  • Shareholder attrition: shareholder count fell from 43,140 (Sep 2023) to 36,206 (Jun 2026) (Screener).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Stock down ~35% over the prior year; trading near ₹8.2 TrendlyneSentiment backdrop
May 2025FY2025 audited results (loss year; magnitude disputed) Multiple vendorsSecond loss in three years
Aug 2025Q1 FY2026 results: return to profit Screener; Investywise comparativeStart of FY2026 recovery
29 Sep 202542nd AGM held; "Change in Management" disclosure filed Emkay/Dion Global–
1 Oct 2025AGM voting results and scrutiniser's reports filed EmkayRoutine
16 Oct 2025Sep 2025 shareholding pattern filed: promoters 26.58% Emkay/Dion GlobalStable control
10–11 Nov 2025Board meeting rescheduled from 11 Nov to 14 Nov 2025 Axis Direct / Capital MarketMinor
14 Nov 2025Q2 FY2026: standalone net profit ₹9.33 cr; consolidated ₹10.99 cr vs loss ₹9.53 cr a year earlier Dion Global; Capital MarketH1 FY2026 strong
17 Nov 2025Newspaper publication of results ScanXRoutine
24 Dec 2025Stock at ₹8.49; P/E 4.7, P/B 0.40 ICICIdirectValuation marker
5 Feb 2026Board meeting intimation for Q3 results ScreenerRoutine
10 Feb 2026Q3 FY2026: standalone loss ₹40.5 cr; fair-value loss on investments ₹39.28 cr; both segments loss-making Dion Global; ScanXLargest quarterly loss in the period
Feb 202652-week low region (₹6.30–6.60) Kotak NeoMarket reaction
17 Mar 2026CFO Amit Mehta resignation disclosed (effective 31 Mar 2026) ScreenerFinance-function turnover
30 Mar 2026Stock closes at ₹5.07 (52-week low ₹5.01) Screener snapshotTrough
1 Apr 2026Reg 30 confirmation of CFO cessation ScanXRoutine
Apr 2026Q4 FY2026 dematerialisation certificate filed ScanXRoutine
27 May 2026FY2026 audited results: standalone PAT ₹6.63 cr vs FY2025 loss ₹5.98 cr; TCI loss ₹34.27 cr; unmodified audit opinion; board meeting ran ~4 hours Investywise; GrowwHeadline turnaround masks equity erosion
29 May 2026Results newspaper publication ScanXRoutine
12 Jun 2026Secretarial auditor resigns ScanXGovernance flag
29 Jun 2026Praveen Jangid appointed CFO ScanXFills 3-month vacancy
10 Jul 2026Revised auditor's report filed after BSE formatting query; figures unchanged ScanXCompliance quality flag
14 Aug 2026Q1 FY2027: income ₹2.99 cr; PAT ₹2.87 cr vs ₹0.69 cr; TCI ₹29.34 cr (standalone) / ₹35.11 cr (consolidated) on fair-value recovery; Jay Bhatt & Associates appointed secretarial auditor InvestywiseRecovery in investment marks
2 Sep 2026AGM notice and book-closure announcement IIFLRoutine
24 Sep 202643rd AGM: all resolutions passed incl. Kulhriya second term, five-year secretarial auditor, related-party approval Screener/BSEBoard continuity
28 Sep 2026Voting results and scrutiniser's report filed ScreenerRoutine
29 Sep 2026Trading window closed from 1 Oct 2026 for Q2 FY2027 results ScreenerResults expected ~mid-Nov 2026
14 Oct 2026Reg 74(5) depository compliance certificate filed ScreenerRoutine
Ongoing 2026MarketsMojo rates the stock "Strong Sell" (repeated)Quant-rating sentiment

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment: Commodity/Trading segment revenue held from INR 0 Mn in 2025 to INR 0 Mn in 2027.
Banas Finance Limited — Revenue by Segment
Series (INR Mn)202520262027
Commodity/Trading segment revenue0129.50
Finance segment revenue025.929.9
Finance segment PBT-73028.6
Commodity/Trading segment result0-38.20

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Screener.in – Banas Finance consolidated financials, shareholding, announcements, annual-report links (accessed Oct 2026) (screener.in)
  2. StockAnalysis – Income statement FY2022–FY2026 (S&P data) (stockanalysis.com)
  3. Investywise – FY2026 results and 43rd AGM notice (investywise.com)
  4. Investywise – Q1 FY2027 results and secretarial auditor: and: investywise.com · investywise.com
  5. Investywise – Secretarial auditor five-year appointment (investywise.com)
  6. ScanX – Revised auditor report; CFO appointment; Q3 FY2026 loss; CFO resignation · scanx.trade · scanx.trade
  7. HDFC Securities / Capital Market – FY2026 and quarterly news (hdfcsec.com)
  8. Emkay / Dion Global – Q3 FY2026 loss; shareholding Sep & Dec 2025 · emkayglobal.com · emkayglobal.com
  9. Kotak Neo – Q4 FY2026 results (kotakneo.com)
  10. IIFL / India Infoline – revenue history, balance sheet, shareholding, board-meeting register · live-next.indiainfoline.com · indiainfoline.com
  11. BSE filing – Rights Issue Final Letter of Offer (May 2024) (bseindia.com)
  12. BSE filing – Rights allotment (5 Jun 2024) (bseindia.com)
  13. BSE filings – Board outcomes 16 Jan 2024, 30 Jan 2024, 6 Sep 2023, 18 Apr 2024, 11 Apr 2024, 10 Aug 2024 (via bseindia.com corpfiling attachments)
  14. BSE filing – Amalgamation record date (Aug 2020) (bseindia.com)
  15. Business Standard – Board approves Scheme of Amalgamation (15 May 2018) (business-standard.com)
  16. Goodreturns – Directors' Report FY2025 (auditors) (goodreturns.in)
  17. Simply Wall St – company information and management (simplywall.st)
  18. MarketsMojo – company CV, shareholding, corporate actions (marketsmojo.motilaloswal.com)
  19. TheCompanyCheck – CIN and director appointment dates (thecompanycheck.com)
  20. Upstox / Pocketful / IIFL – shareholding Jun 2026 (upstox.com)
  21. Value Research – valuation and peer medians (Jun 2026) (valueresearchonline.com)
  22. Fyers – Q1 FY2027 and peer table (fyers.in)
  23. Anand Rathi – price and returns (Sep 2026) (anandrathi.com)
  24. Groww – company description and 2026 news (groww.in)
  25. Blinkx – board of directors (blinkx.in)
  26. MarketScreener – Anant Chourasia profile (es.marketscreener.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.